Kay Andrew
Chairman
Board Member
Wilson Therapeutics
Sweden
Biography
Education: BPharm Hons, Nottingham University. Other current assignments: Chairman of Blueberry Therapeutics, director of Amulet Consulting and senior advisor of HealthCap. Previous assignments (last five years): CEO of Algeta ASA. Position: Independent of the Company, executive management and major shareholders. Holdings in the Company: 7,088 shares, 255,000 stock options and 24,000 performance shares Board LTIP 2016.
Research Interest
